Back to results
US 2025/0032593 A1Published application
Eukaryotic elongation factor-2 kinase as a cytotoxic t lymphocytes booster
AssigneeThe Texas A&M University System
InventorJianxun Jim Song
Life of this patent
Estimating the term…
Abstract
In an embodiment, the present disclosure pertains to a method of reducing cytocidal activity of cells. In some embodiments, the method includes altering eukaryotic elongation factor-2 kinase (eEF-2K) in a subject and inducing a reduction of cytocidal activity of cytotoxic T cells (CTLs) in the subject. In some embodiments, the altering of eEF-2K in the subject can include a decrease of eEF-2K in the subject.
Claims20
A method of reducing cytocidal activity of cells, the method comprising:
- altering eukaryotic elongation factor-2 kinase (eEF-2K) in a subject;
- and
- inducing a reduction of cytocidal activity of cytotoxic T cells (CTLs) in the subject.
Dependencies are inferred from the claim text.